Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000095

CEO bought 20,000 shares at an average $0.13 ($2,515)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-10-07 Purchase : show line 1 in the form +10,000 $0.13 $1,290 7,225,579 D
2016-10-07 Purchase : show line 2 in the form +5,000 $0.13 $625 7,230,579 D
2016-10-07 Purchase : show line 3 in the form +5,000 $0.12 $600 7,235,579 D
Open-market purchases · 20,000 sh · avg $0.13 · $2,515
Loading xslF345X03/primary_doc.xml…